Evidence map›Paper›PMID 25346942›Full record

ArticleAIMS public health2014

Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study.

Olaoluwa Okusaga, Robert G Hamilton, Adem Can, Ajirioghene Igbide, Ina Giegling, Annette M Hartmann, Bettina Konte, Marion Friedl, Gloria M Reeves, Dan Rujescu and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIMS public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Olaoluwa OkusagaMood and Anxiety Program, University of Maryland School of Medicine, Baltimore, MD USA ; Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, TX, USA.
Robert G HamiltonJohns Hopkins Dermatology, Allergy and Clinical Immunology Reference Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD USA.
Adem CanMood and Anxiety Program, University of Maryland School of Medicine, Baltimore, MD USA.
Ajirioghene IgbideMood and Anxiety Program, University of Maryland School of Medicine, Baltimore, MD USA ; St. Elizabeths Hospital, Psychiatry Residency Training Program, Washington, DC, USA.
Ina GieglingDepartment of Psychiatry, University of Halle-Wittenberg, Germany.
Annette M HartmannDepartment of Psychiatry, University of Halle-Wittenberg, Germany.
Bettina KonteDepartment of Psychiatry, University of Halle-Wittenberg, Germany.
Marion FriedlDepartment of Psychiatry, University of Halle-Wittenberg, Germany.
Gloria M ReevesDivision of Child and Adolescent Psychiatry, University of Maryland, School of Medicine, Baltimore, Maryland, USA ; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA.
Dan RujescuDepartment of Psychiatry, University of Halle-Wittenberg, Germany.
Teodor T PostolacheMood and Anxiety Program, University of Maryland School of Medicine, Baltimore, MD USA ; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA.
Martin Luther University Halle-Wittenberg · DEJohns Hopkins University · USUniversity of Maryland, Baltimore · US

Funding

SEASONALITY OF SUICIDE AND AIRBORNE ALLERGENSR01MH074891 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI POSTOLACHE, TEODOR T · 2007 to 2009
$1.0M
NIMH NIH HHS R01 MH074891
6 · The paper itself

Abstract

There is a dearth of information on the association of atopy with schizophrenia. The few available studies used population-based registers to classify the atopy status of the patients but this strategy is not reliable. This study measured seropositivity with a multiallergen screen of allergen specific IgE antibodies in schizophrenia patients versus healthy controls. A subset of 66 schizophrenia patients and 34 healthy controls were randomly selected from a large comparative study of schizophrenia patients and controls. The Phadiatop multi-allergen screen was performed on sera from all the participants to assess their atopic status. Logistic regression was used to calculate the odds ratio for the association of schizophrenia with Phadiatop seropositivity as a measure of atopy. The prevalence of Phadiatop seropositivity was significantly lower (χ

Indexed as

allergenallergyatopyIgEimmunologyPhadiatopschizophrenia

Identifiers

PMID25346942
PMCPMC4205967
OpenAlexW2155128456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.